Modified Low Power Mode Laser for the Treatment of Central Serous Chorioretinopathy

被引:2
作者
Miura, Masahiro [1 ]
Wakita, Ryo [1 ]
Iwasaki, Takuya [1 ]
机构
[1] Tokyo Med Univ, Ibaraki Med Ctr, Dept Ophthalmol, 3-20-1 Chuo, Inashiki, Ibaraki 3000395, Japan
来源
CLINICAL OPHTHALMOLOGY | 2020年 / 14卷
关键词
central serous chorioretinopathy; subthreshold laser; low power mode; photocoagulation; PHOTOCOAGULATION; THERAPY;
D O I
10.2147/OPTH.S284005
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Low power mode (LPM) can be used for subthreshold retinal laser treatment by simply adjusting the laser parameters. Herein, we report the use of a modified LPM laser treatment for four cases of central serous chorioretinopathy (CSCR). Patients and Methods: We retrospectively reviewed the medical records of four patients (four eyes) with persistent CSCR who underwent modified LPM laser for leakage. The laser power was first titrated with a barely visible burn, and then treatment was applied using 33% laser energy by manually adjusting the laser power and duration. Results: Serous retinal detachment completely resolved in all cases by 2 months after treatment. Autofluorescence images did not show any specific changes induced by laser burns. Conclusion: A modified LPM laser may provide a feasible treatment for persistent CSCR.
引用
收藏
页码:4109 / 4113
页数:5
相关论文
共 9 条
  • [1] Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
    Daruich, Alejandra
    Matet, Alexandre
    Dirani, Ali
    Bousquet, Elodie
    Zhao, Min
    Farman, Nicolette
    Jaisser, Frederic
    Behar-Cohen, Francine
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2015, 48 : 82 - 118
  • [2] Micropulse Laser Treatment of Retinal Diseases
    Gawecki, Maciej
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [3] Micropulse diode laser photocoagulation for central serous chorio-retinopathy
    Gupta, Bhaskar
    Elagouz, Mohammed
    McHugh, Dominic
    Chong, Victor
    Sivaprasad, Sobha
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (08) : 801 - 805
  • [4] Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy
    Koss, M. J.
    Berger, I.
    Koch, F. H.
    [J]. EYE, 2012, 26 (02) : 307 - 314
  • [5] Nondamaging Retinal Laser Therapy: Rationale and Applications to the Macula
    Lavinsky, Daniel
    Wang, Jenny
    Huie, Philip
    Dalal, Roopa
    Lee, Seung Jun
    Lee, Dae Yeong
    Palanker, Daniel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (06) : 2488 - 2500
  • [6] RESPONSE OF THE RETINAL-PIGMENT EPITHELIUM TO SELECTIVE PHOTOCOAGULATION
    ROIDER, J
    MICHAUD, NA
    FLOTTE, TJ
    BIRNGRUBER, R
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (12) : 1786 - 1792
  • [7] Non-damaging Retinal Phototherapy: Dynamic Range of Heat Shock Protein Expression
    Sramek, Christopher
    Mackanos, Mark
    Spitler, Ryan
    Leung, Loh-Shan
    Nomoto, Hiroyuki
    Contag, Christopher H.
    Palanker, Daniel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (03) : 1780 - 1787
  • [8] Central serous chorioretinopathy: Towards an evidence-based treatment guideline
    van Rijssen, Thomas J.
    van Dijka, Elon H. C.
    Yzer, Suzanne
    Ohno-Matsui, Kyoko
    Keunen, Jan E. E.
    Schlingemann, Reinier O.
    Sivaprasad, Sobha
    Querques, Giuseppe
    Downes, Susan M.
    Fauser, Sascha
    Hoyng, Carel B.
    Piccolino, Felice Cardillo
    Chhablani, Jay K.
    Lai, Timothy Y. Y.
    Lotery, Andrew J.
    Larsen, Michael
    Holz, Frank G.
    Freund, K. Bailey
    Yannuzzi, Lawrence A.
    Boon, Camiel J. F.
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2019, 73
  • [9] NONDAMAGING RETINAL LASER THERAPY FOR TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY What is the Evidence?
    Wood, Edward H.
    Karth, Peter A.
    Sanislo, Steven R.
    Moshfeghi, Darius M.
    Palanker, Daniel V.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1021 - 1033